The Expanding Role of SGLT2 inhibitors in Kidney Care

Includes a Live Web Event on 09/28/2026 at 11:00 AM (EDT)

This presentation will provide an overview of sodium-glucose cotransporter 2 (SGLT2) inhibitors and their role in the management of chronic kidney disease. Attendees will learn about the mechanism of action, clinical benefits, safety considerations, and monitoring requirements associated with these medications. The session will also highlight current guideline recommendations.

CE Credit: 1.00 | Post-Webinar Survey Required

Presented September 2026

Jill M. Frament, RPh., PharmD

Jill M. Frament, RPh., PharmD

Clinical Pharmacist

REACH Kidney Care

Dr. Frament is a Clinical Pharmacist with experience in ambulatory, institutional, and community care settings.  She received her Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences in 2015. Following graduation, she went on to complete an accredited pharmacy practice residency at St. Peter’s Hospital, in Albany, NY.  She has been practicing with a focus on kidney care for nearly ten years.   

Key:

Complete
Failed
Available
Locked
The Expanding Role of SGLT2 inhibitors in Kidney Care Webinar
09/28/2026 at 11:00 AM (EDT)  |  60 minutes
09/28/2026 at 11:00 AM (EDT)  |  60 minutes This presentation will provide an overview of sodium-glucose cotransporter 2 (SGLT2) inhibitors and their role in the management of chronic kidney disease. Attendees will learn about the mechanism of action, clinical benefits, safety considerations, and monitoring requirements associated with these medications. The session will also highlight current guideline recommendations.
You must register to access.
The Expanding Role of SGLT2 inhibitors in Kidney Care Post-Webinar Survey
4 Questions
4 Questions
You must register to access.
The Expanding Role of SGLT2 inhibitors in Kidney Care CE Certificate
1.00 CE credit  |  Certificate available
1.00 CE credit  |  Certificate available
You must register to access.